(R)-2-(2-Hydroxy-3-((2-hydroxyethyl)(phenyl)amino)propyl)isoindoline-1,3-dione
- CAS
- 1175817-46-5
- Formula
- C19H20N2O4
- MW
- 340.37 g/mol
VQ-041957
Impurity reference standards
Rivaroxaban impurities & reference standards
Characterised Rivaroxaban impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
130reference materials
11nitrosamine impurities
1isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Rivaroxaban WS
366789-02-8 · C19H18ClN3O5S
(R)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one
- CAS
- 1411775-06-8
- Formula
- C14H17N3O4
- MW
- 291.3 g/mol
VQ-043471
(R)-4-(4-(5-(Aminomethyl)-2-Oxooxazolidin-3-yl)phenyl)Morpholin-3-one Hydrochloride
- CAS
- 1429311-47-6
- Formula
- C14H18ClN3O4
- MW
- 327.76 g/mol
VQ-041959
(R)-4-(4-(5-(Chloromethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one
- CAS
- 1252018-28-2
- Formula
- C14H15ClN2O4
- MW
- 310.73 g/mol
VQ-033608
(S)-(3-(5-Chlorothiophene-2-carboxamido)-2-hydroxypropyl)(4-(3-oxomorpholino)phenyl)carbamic acid
- CAS
- 2304798-51-2
- Formula
- C19H20ClN3O6S
- MW
- 453.9 g/mol
VQ-033613
(S)-2-((2-Oxo-3-phenyloxazolidin-5-yl)methyl)isoindoline-1,3-dione
- CAS
- 2137914-93-1
- Formula
- C18H14N2O4
- MW
- 322.3 g/mol
VQ-033602
(S)-4-(4-((2,3-Dihydroxypropyl)amino)phenyl)morpholin-3-one
- CAS
- 2733521-54-3
- Formula
- C13H18N2O4
- MW
- 266.29 g/mol
VQ-041956
(S)-4-(4-((3-Amino-2-hydroxypropyl)amino)phenyl)morpholin-3-one Dihydrochloride
- CAS
- 2304439-07-2
- Formula
- C13H21Cl2N3O3
- MW
- 338.2 g/mol
VQ-041953
(S)-4-(4-(5-(Hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one
- CAS
- 2733280-11-8
- Formula
- C14H16N2O5
- MW
- 292.29 g/mol
VQ-033609
(S)-5-Chloro-N-((2-oxo-3-phenyloxazolidin-5-yl)methyl)thiophene-2-carboxamide
- CAS
- 2376189-86-3
- Formula
- C15H13ClN2O3S
- MW
- 336.79 g/mol
VQ-033611
(S)-5-Chloro-N-(2,3-dihydroxypropyl)thiophene-2-carboxamide
- CAS
- 721401-51-0
- Formula
- C8H10ClNO3S
- MW
- 235.69 g/mol
VQ-041955
(S)-N-((3-(4-Acetamidophenyl)-2-oxooxazolidin-5-yl)methyl)-5-chlorothiophene-2-carboxamide
- CAS
- 2422046-61-3
- Formula
- C17H16ClN3O4S
- MW
- 393.8 g/mol
VQ-027857
2 2 Oxo 1 3 dioxolan 4 yl methyl isoindoline 1 3 dione
- CAS
- 1218777-30-0
- Formula
- C12H9NO5
- MW
- 247.2 g/mol
VQ-041954
2-(2-Chloroethoxy)-N-(4-nitrophenyl)acetamide
- CAS
- 811450-82-5
- Formula
- C10H11ClN2O4
- MW
- 258.66 g/mol
VQ-041964
![2-[(2S)-2,3-Dihydroxypropyl]-1H-isoindole-1,3(2H)-dione chemical structure](/media/structures/GUUVCKWUQHAMTB-ZETCQYMHSA-N.svg)
2-[(2S)-2,3-Dihydroxypropyl]-1H-isoindole-1,3(2H)-dione
- CAS
- 119835-88-0
- Formula
- C11H11NO4
- MW
- 221.21 g/mol
VQ-033604
![2-[2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]ethoxy]-acetic Acid Hydrochloride chemical structure](/media/structures/UFNIIYAHXMBQSV-UQKRIMTDSA-N.svg)
2-[2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]ethoxy]-acetic Acid Hydrochloride
- CAS
- 931117-61-2
- Formula
- C19H21Cl2N3O6S
- MW
- 490.4 g/mol
VQ-027846
2,2'-((2R,2'R)-((4-(3-Oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione)
- CAS
- 1643354-27-1
- Formula
- C32H30N4O8
- MW
- 598.6 g/mol
VQ-027858
4-(4-Aminophenyl)-3-morpholinone hydrochloride
- CAS
- 1640884-60-1
- Formula
- C10H12N2O2.ClH
- MW
- 230.67 g/mol
VQ-013060
![4-[4-(3-Aminopropylamino)phenyl]morpholin-3-one chemical structure](/media/structures/KQUBZYJUHGQSHR-UHFFFAOYSA-N.svg)
4-[4-(3-Aminopropylamino)phenyl]morpholin-3-one
- CAS
- 1816946-19-6
- Formula
- C13H19N3O2
- MW
- 249.31 g/mol
VQ-045368
4-Nitrophenyl 5-chlorothiophene-2-carboxylate
- CAS
- 1450877-56-1
- Formula
- C11H6ClNO4S
- MW
- 283.69 g/mol
VQ-039653
N-Nitroso Rivaroxaban Open-Ring Acid Impurity
- CAS
- 3069765-41-6
- Formula
- C19H19ClN4O7S
- MW
- 482.9 g/mol
VQ-033612
Rac-Rivaroxaban Diphthalimido Morpholinone Analog
- CAS
- 1642600-99-4
- Formula
- C32H30N4O8
- MW
- 598.6 g/mol
VQ-033607
FAQs — Rivaroxaban impurities
Which Rivaroxaban impurities do you supply?
We list 130 Rivaroxaban-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Rivaroxaban impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Rivaroxaban impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Rivaroxaban impurity standards
We reply within one business day with price, pack options, lead time and documentation.